MyAverix Finance
US · Healthcare
CSL Ltd (CSLLY)
Biotechnology
CSL Ltd (CSLLY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CSLLY
P/E ratio
18.00
CSL Ltd (CSLLY) — FAQ
What is CSLLY's P/E ratio?
The price-to-earnings (P/E) ratio for CSL Ltd (CSLLY) is 18.00 (data as of 2026-03-24).
Does CSL Ltd pay a dividend?
Dividend yield is not available in the current snapshot for CSL Ltd (CSLLY). Check the MyAverix Finance app for the latest dividend data.
What sector is CSL Ltd in?
CSL Ltd (CSLLY) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CSLLY listed on?
CSLLY is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.